RNAi Therapeutics

Pages

▼
Showing posts with label kallikrein-kinin. Show all posts
Showing posts with label kallikrein-kinin. Show all posts
Friday, April 3, 2015

Hereditary Angioedema: A High-Value RNA Therapeutics Target Confirmed by Antibody Trial

›
This week, Dyax released early , but arguably impressive data from a phase Ib trial of monoclonal antibody DX-2930 for the prophylaxis o...
1 comment:
›
Home
View web version
Powered by Blogger.